Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5007 USD | +6.13% | +0.04% | -52.33% |
05-28 | Evoke Pharma, Inc. Appoints Mark A. Kowieski as Chief Financial Officer | CI |
05-14 | Evoke Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 13.68M 18.74M | Sales 2025 * | 21.9M 30.01M | Capitalization | 4.06M 5.56M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.37M | Net income 2025 * | 3M 4.11M | EV / Sales 2024 * | 0.3 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.19 x |
P/E ratio 2024 * |
-5.9
x | P/E ratio 2025 * |
4.72
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.09% |
Latest transcript on Evoke Pharma, Inc.
1 day | +6.13% | ||
1 week | +0.04% | ||
Current month | -5.35% | ||
1 month | -0.85% | ||
3 months | -18.29% | ||
6 months | -51.39% | ||
Current year | -52.33% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 54 | 06-12-31 | |
Marilyn Carlson
CTO | Chief Tech/Sci/R&D Officer | 76 | 13-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cam Garner
FOU | Founder | 75 | 06-12-31 |
Kenneth Widder
BRD | Director/Board Member | 71 | 07-05-31 |
Todd Brady
BRD | Director/Board Member | 52 | 07-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 0.5007 | +6.13% | 44 374 |
24-07-01 | 0.4718 | -10.81% | 23,794 |
24-06-28 | 0.529 | +5.48% | 10,952 |
24-06-27 | 0.5015 | -7.13% | 19,103 |
24-06-26 | 0.54 | +7.89% | 10,995 |
Delayed Quote Nasdaq, July 02, 2024 at 10:15 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.33% | 4.06M | |
+51.71% | 823B | |
+40.34% | 641B | |
-6.39% | 352B | |
+16.58% | 324B | |
+7.93% | 301B | |
+14.04% | 241B | |
+1.76% | 223B | |
+13.24% | 218B | |
+7.12% | 167B |
- Stock Market
- Equities
- EVOK Stock